The St. George's Respiratory Questionnaire as a prognostic factor in IPF

被引:60
作者
Furukawa, Taiki [1 ]
Taniguchi, Hiroyuki [1 ]
Ando, Masahiko [2 ]
Kondoh, Yasuhiro [1 ]
Kataoka, Kensuke [1 ]
Nishiyama, Osamu [3 ]
Johkoh, Takeshi [4 ]
Fukuoka, Junya [5 ]
Sakamoto, Koji [6 ]
Hasegawa, Yoshinori [6 ]
机构
[1] Tosei Gen Hosp, Dept Resp Med & Allergy, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan
[2] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668650, Japan
[3] Kindai Univ, Dept Resp Med & Allergol, Fac Med, 377-2 Onohigashi, Osaka, Osaka 5898511, Japan
[4] Kinki Cent Hosp, Mutual Aid Assoc Publ Hlth Teachers, Dept Radiol, Itami, Hyogo 6648533, Japan
[5] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan
[6] Nagoya Univ, Grad Sch Med, Dept Resp Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
来源
RESPIRATORY RESEARCH | 2017年 / 18卷
关键词
Health related QoL; Idiopathic pulmonary fibrosis; Prognostic factors; The St. George's Respiratory Questionnaire; IDIOPATHIC PULMONARY-FIBROSIS; QUALITY-OF-LIFE; EXERCISE CAPACITY; HEALTH-STATUS; MORTALITY; DISEASE; EFFICACY; DISTANCE; TRIAL; STANDARDIZATION;
D O I
10.1186/s12931-017-0503-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: It is unclear whether health related quality of life (HRQL) may have a predictive value for mortality in idiopathic pulmonary fibrosis (IPF). We investigated the relationship between HRQL assessed using the St. George's Respiratory Questionnaire (SGRQ) and survival time in patients with IPF, and tried to determine a clinical meaningful cut off value to predict poorer survival rates. Methods: We retrospectively analyzed consecutive patients with IPF who underwent an initial evaluation from May 2007 to December 2012. The diagnosis of IPF was made according to the 2011 international consensus guidelines. We used Cox proportional hazard models to identify independent predictors for mortality rate in patients with IPF. Results: We examined 182 eligible cases, average age was 66 years old, and 86% were male. Mean levels of percent predicted FVC, DLco, six-minute-walk test distance, and the SGRQ total score were around 80%, 58%, 580 m, and 34 points. On multivariate analysis, the SGRQ total score (hazard ratio [HR], 1.012; 95% confidence interval [CI] 1.001-1.023; P = .029) and percent predicted FVC (HR, 0.957; 95% CI 0.944-0.971, P < .001) were independent predictors for mortality rate. Moreover, a score higher than 30 points in the SGRQ total score showed higher mortality rate (HR, 2.047; 95% CI, 1.329-3.153; P = .001). Conclusions: The SGRQ total score was one of independent prognostic factors in patients with IPF. Total scores higher than 30 points were associated with higher mortality rates.
引用
收藏
页数:6
相关论文
共 33 条
  • [21] Nishiyama O, 2012, SARCOIDOSIS VASC DIF, V29, P113
  • [22] A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
    Nishiyama, O.
    Taniguchi, H.
    Kondoh, Y.
    Kimura, T.
    Kato, K.
    Kataoka, K.
    Ogawa, T.
    Watanabe, F.
    Arizono, S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (05) : 1067 - 1072
  • [23] Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
    Nishiyama, Osamu
    Kondoh, Yasuhiro
    Kimura, Tomoki
    Kato, Keisuke
    Kataoka, Kensuke
    Ogawa, Tomoya
    Watanabe, Fumiko
    Arizono, Shinichi
    Nishimura, Koichi
    Taniguchi, Hiroyuki
    [J]. RESPIROLOGY, 2008, 13 (03) : 394 - 399
  • [24] Analysis of the factors related to mortality in chronic obstructive pulmonary disease - Role of exercise capacity and health status
    Oga, T
    Nishimura, K
    Tsukino, M
    Sato, S
    Hajiro, T
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (04) : 544 - 549
  • [25] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
    Raghu, G
    Brown, KK
    Bradford, WZ
    Starko, K
    Noble, PW
    Schwartz, DA
    King, TE
    Adlakha, A
    Tarczynski, S
    Ainslie, G
    Kalam, R
    Bai, T
    Truchan, H
    Baughman, R
    Wingst, D
    Bhorade, S
    Norwick, L
    Brown, KK
    Kervitsky, D
    Calhoun, W
    DiNella, L
    Chan, C
    Jamieson, L
    Chan, K
    Turpen, T
    Chapman, J
    Slattery, S
    Chen, L
    Turner, J
    Clark, M
    Sanders, R
    Crain, M
    Pate, D
    Davis, G
    Lynn, M
    Dhar, A
    Hrytsytk, M
    Drent, M
    Horr, ET
    du Bois, R
    Goh, N
    Egan, J
    Anthony, N
    Enelow, R
    Haram, T
    Ettinger, N
    Merli, S
    Frost, A
    Holy, R
    Glassberg, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (02) : 125 - 133
  • [26] Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
    Raghu, G.
    King, T. E., Jr.
    Behr, J.
    Brown, K. K.
    du Bois, R. M.
    Leconte, I.
    Roux, S.
    Swigris, J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) : 118 - 123
  • [27] An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
    Raghu, Ganesh
    Collard, Harold R.
    Egan, Jim J.
    Martinez, Fernando J.
    Behr, Juergen
    Brown, Kevin K.
    Colby, Thomas V.
    Cordier, Jean-Francois
    Flaherty, Kevin R.
    Lasky, Joseph A.
    Lynch, David A.
    Ryu, Jay H.
    Swigris, Jeffrey J.
    Wells, Athol U.
    Ancochea, Julio
    Bouros, Demosthenes
    Carvalho, Carlos
    Costabel, Ulrich
    Ebina, Masahito
    Hansell, David M.
    Johkoh, Takeshi
    Kim, Dong Soon
    King, Talmadge E., Jr.
    Kondoh, Yasuhiro
    Myers, Jeffrey
    Mueller, Nestor L.
    Nicholson, Andrew G.
    Richeldi, Luca
    Selman, Moises
    Dudden, Rosalind F.
    Griss, Barbara S.
    Protzko, Shandra L.
    Schuenemann, Holger J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (06) : 788 - 824
  • [28] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    du Bois, Roland M.
    Raghu, Ganesh
    Azuma, Arata
    Brown, Kevin K.
    Costabel, Ulrich
    Cottin, Vincent
    Flaherty, Kevin R.
    Hansell, David M.
    Inoue, Yoshikazu
    Kim, Dong Soon
    Kolb, Martin
    Nicholson, Andrew G.
    Noble, Paul W.
    Selman, Moises
    Taniguchi, Hiroyuki
    Brun, Michele
    Le Maulf, Florence
    Girard, Mannaig
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Disse, Bernd
    Collard, Harold R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) : 2071 - 2082
  • [29] Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    Costabel, Ulrich
    Selman, Moises
    Kim, Dong Soon
    Hansell, David M.
    Nicholson, Andrew G.
    Brown, Kevin K.
    Flaherty, Kevin R.
    Noble, Paul W.
    Raghu, Ganesh
    Brun, Michele
    Gupta, Abhya
    Juhel, Nolwenn
    Klueglich, Matthias
    du Bois, Roland M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) : 1079 - 1087
  • [30] The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review
    Swigris, Jeffrey J.
    Esser, Dirk
    Conoscenti, Craig S.
    Brown, Kevin K.
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12